What’s New

Latest News

Clinical Trials
Surrogate Endpoints Remain a Challenge in Interventional Oncology Trials
05/12/2026
Laura Simson, MA
A 2026 review article examined the strengths and limitations of surrogate endpoints in interventional oncology clinical trials.
A 2026 review article examined the strengths and limitations of surrogate endpoints in interventional oncology clinical trials.
A 2026 review article examined...
05/12/2026
Vascular Disease Management
Vascular Disease Management
News
test
05/12/2026
05/12/2026
Journal of Clinical Pathways
Journal of Clinical Pathways
A man with depression holds his head in his hands
News
Lumateperone Tops Efficacy in Adjunctive Treatment for MDD, Review Finds
05/12/2026
Brionna Mendoza
A new systematic review and network meta-analysis published in JAMA Psychiatry evaluated the comparative efficacy and acceptability of the 5 FDA-approved atypical antipsychotics used as adjunctive therapy for major depressive disorder (MDD).
A new systematic review and network meta-analysis published in JAMA Psychiatry evaluated the comparative efficacy and acceptability of the 5 FDA-approved atypical antipsychotics used as adjunctive therapy for major depressive disorder (MDD).
A new systematic review and...
05/12/2026
Psych Congress Network
Psych Congress Network
News
Oral Icotrokinra Demonstrates High Efficacy and Favorable Safety in Plaque Psoriasis
05/12/2026
Jessica Garlewicz
Investigators analyzed 5 randomized trials including 1951 patients receiving icotrokinra 200 mg once daily or placebo.
Investigators analyzed 5 randomized trials including 1951 patients receiving icotrokinra 200 mg once daily or placebo.
Investigators analyzed 5...
05/12/2026
The Dermatologist
The Dermatologist
ACEP and NAEMT Announce EMS Week 2026
Press Release
ACEP and NAEMT Announce EMS Week 2026
05/12/2026
EMS World is a media partner of the event, now in its 52nd year.
EMS World is a media partner of the event, now in its 52nd year.
EMS World is a media partner of...
05/12/2026
EMSWorld
EMSWorld
Conference Coverage
Early Endoscopic and Histologic Response With Guselkumab Predicts Long-Term Remission in UC
05/12/2026
Jessica Garlewicz
In the QUASAR long-term extension study, 72.1% to 81.3% of responders maintained remission at week 92 after treatment with guselkumab.
In the QUASAR long-term extension study, 72.1% to 81.3% of responders maintained remission at week 92 after treatment with guselkumab.
In the QUASAR long-term...
05/12/2026
Advances in Inflammatory Bowel Disease Network
Advances in Inflammatory Bowel Disease Network
News
Trastuzumab Deruxtecan Plus Paclitaxel, Trastuzumab, and Pertuzumab Improves Residual Cancer Burden in HER2-Positive Early Breast Cancer
05/11/2026
Stephanie Holland
Post hoc analysis results from the phase 3 DESTINY-Breast11 trial demonstrated that neoadjuvant trastuzumab deruxtecan plus paclitaxel, trastuzumab, and pertuzumab improved residual cancer burden and pathologic response in HER2-positive early...
Post hoc analysis results from the phase 3 DESTINY-Breast11 trial demonstrated that neoadjuvant trastuzumab deruxtecan plus paclitaxel, trastuzumab, and pertuzumab improved residual cancer burden and pathologic response in HER2-positive early...
Post hoc analysis results from...
05/11/2026
Oncology
Oncology

Latest Research

Vascular Disease Management logo
Vascular Disease Management
Tackling the Calcium Challenge: Managing Recoil, Rupture, and Occlusion
Vol. 23, Issue 4, Issue May 2026
April/May 2026 cover
The Dermatologist
Evolution of Aesthetics in Dermatology
Vol. 34, Issue 3, Issue May 2026

HMP Global Learning Network

Featured Interviews

CTP News Desk Image
Viewpoint
Operational Observations in a New CTP Regulatory Environment
05/08/2026
Nikki Johnston; Kati Kaushal, DNP, FNP-C, CWS
Learn more about these consultants' observations in this new regulatory environment.
Learn more about these consultants' observations in this new regulatory environment.
Learn more about these...
05/08/2026
Wounds
Advances in Charcot Neuroarthropathy Surgical Techniques Video
Videos
Advances in Charcot Neuroarthropathy Surgical Techniques Video
05/01/2026
Zeeshan S. Husain, DPM, FACFAS, FASPS; Athanasios Garbis, DPM; Kyle Lawton, DPM
In this video, we highlight emerging reconstruction strategies that move beyond traditional rigid fixation toward a more functional approach to limb preservation.
In this video, we highlight emerging reconstruction strategies that move beyond traditional rigid fixation toward a more functional approach to limb preservation.
In this video, we highlight...
05/01/2026
Podiatry Today
Jonathan Friedberg, MD
Videos
Nivolumab Plus Doxorubicin, Vinblastine, and Dacarbazine in Advanced Hodgkin Lymphoma
04/30/2026
Jonathan W. Friedberg, MD, MMSc
Jonathan Friedberg, MD, MMSc, discusses results from the SWOG S1826 trial which led to the recent FDA approval of nivolumab plus doxorubicin, vinblastine, and dacarbazine for patients with advanced-stage Hodgkin lymphoma.
Jonathan Friedberg, MD, MMSc, discusses results from the SWOG S1826 trial which led to the recent FDA approval of nivolumab plus doxorubicin, vinblastine, and dacarbazine for patients with advanced-stage Hodgkin lymphoma.
Jonathan Friedberg, MD, MMSc,...
04/30/2026
Oncology
Advanced Squamous Cell Carcinoma of the Anal Canal
Videos
Evaluating Retifanlimab for Advanced Squamous Cell Carcinoma of the Anal Canal in the Frontline Setting
03/31/2026
Lingbin Meng, MD, PhD
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how...
03/31/2026
First Report Managed Care
Rachid Baz, MD
Videos
BCMA-Targeted Bispecifics and CAR-T in Frontline Multiple Myeloma
03/31/2026
Rachid Baz, MD
Rachid Baz, MD, discusses the emerging role of BCMA-targeted bispecific antibodies and CAR T-cell therapy in transplant-ineligible patients with newly diagnosed multiple myeloma.
Rachid Baz, MD, discusses the emerging role of BCMA-targeted bispecific antibodies and CAR T-cell therapy in transplant-ineligible patients with newly diagnosed multiple myeloma.
Rachid Baz, MD, discusses the...
03/31/2026
Oncology
Al B. Benson, III, MD, FACP, FASCO
Videos
First-Line Immunotherapy in Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC): Evidence Review
03/31/2026
Al B. Benson, III, MD, FACP, FASCO
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the...
03/31/2026
First Report Managed Care
Ira Zackon, MD
Videos
Real-World Analysis Finds Venetoclax-Based Induction Effective for Very Elderly Patients With Acute Myeloid Leukemia
03/02/2026
Ira Zackon, MD
Ira Zackon, MD, shared results from a large real-world analysis which found venetoclax plus a hypomethylating agent is a feasible and effective therapeutic option for patients with AML aged 70 years and older.
Ira Zackon, MD, shared results from a large real-world analysis which found venetoclax plus a hypomethylating agent is a feasible and effective therapeutic option for patients with AML aged 70 years and older.
Ira Zackon, MD, shared results...
03/02/2026
Oncology
Pediatric Video Tutorial: Communicating With Deaf Patients Part 2
Videos
Pediatric Video Tutorial: Communicating With Deaf Patients Part 2
03/02/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
With invaluable insights from a certified interpreter for the deaf, part two of this four-part series rapidly reviews what medical professionals really need to know, and what their deaf patients wish their caregivers knew.
With invaluable insights from a certified interpreter for the deaf, part two of this four-part series rapidly reviews what medical professionals really need to know, and what their deaf patients wish their caregivers knew.
With invaluable insights from a...
03/02/2026
EMSWorld
Allen Kaplan
RESEARCH INSIGHTS
Diagnostic Challenges and Clinical Pitfalls in HAE
03/02/2026
Allen P. Kaplan, MD
Dr Allen Kaplan reviews common diagnostic pitfalls in hereditary angioedema, including misinterpretation of complement testing, confusion with histaminergic angioedema, and challenges in identifying HAE with normal C1 inhibitor.
Dr Allen Kaplan reviews common diagnostic pitfalls in hereditary angioedema, including misinterpretation of complement testing, confusion with histaminergic angioedema, and challenges in identifying HAE with normal C1 inhibitor.
Dr Allen Kaplan reviews common...
03/02/2026
Allergy & Immunology
Zeymer title card
Author Interview
Hospital Outcomes of Patients With Acute Myocardial Infarction-Related Cardiogenic Shock With and Without Revascularization: An Interview With Uwe Zeymer, MD
02/27/2026
Uwe Zeymer, MD
Dr Uwe Zeymer shares background and insights on his article, "Hospital Outcomes of Patients With Acute Myocardial Infarction-Related Cardiogenic Shock With and Without Revascularization."
Dr Uwe Zeymer shares background and insights on his article, "Hospital Outcomes of Patients With Acute Myocardial Infarction-Related Cardiogenic Shock With and Without Revascularization."
Dr Uwe Zeymer shares background...
02/27/2026
Journal of Invasive Cardiology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use